BERYL DRUGS LTD. Share Price

BERYL DRUGS LTD. Share Price

BSE: 524606
|
Pharmaceuticals
|
S Cap
₹ 23.98
+₹0.21 (0.88%)
1D
Last updated 23 Sep, 2026, 15:21 IST

BERYL DRUGS LTD. Share Price Today

As of 24 Sep 2026, BERYL DRUGS LTD. share price is ₹23.98. The stock opened at ₹23.76, compared to its previous close of ₹23.77. During today's trading session, BERYL DRUGS LTD. share price moved in the range of ₹22.60 to ₹24.25, with an average price of ₹23.43 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.92 and a high of ₹27.60.

₹22.60
0.88% up today
₹24.25
1D LOW
1D HIGH

BERYL DRUGS LTD. Returns Calculator

Circuit
L
H
₹19.02
₹28.52
52-week
L
H
₹15.92
₹27.60

About BERYL DRUGS LTD.

BERYL DRUGS LTD. Share Price
ISIN
INE415H01017
Sector Market Cap
₹ 12.16 Cr

Beryl Drugs Limited is an India-based pharmaceutical manufacturing company which is principally engaged in the manufacturing of bulk drugs. The Company operates in Pharmaceutical Industry segment. In response to product requirements, it provides a variety of manufacturing options, such as small volume injectable in liquid or dry powder form, as well as a selection of eye and ear drops, intravenous (IV) fluids in glass bottles and poly packs, and veterinary medications. It is also involved in domestic, institutional and export supply. The Company uses its nationwide sales and distribution network to market a variety of branded and generic pharmaceutical formulations. Its manufacturing facility is in Pithampur, India.

BERYL DRUGS LTD. Financial Highlights

  • Revenue: BERYL DRUGS LTD. reported revenue of ₹19.31 crore in FY26 vs ₹22.55 crore in FY25. It showed a decrease of 14.37% on a yearly basis.
  • Operating Profit: BERYL DRUGS LTD. reported an operating profit of ₹0.59 crore in FY26 vs ₹0.87 crore in FY25. It showed a decrease of 32.18% on a year-on-year basis.
  • Net Profit: BERYL DRUGS LTD. reported a net profit of ₹0.42 crore in FY26 vs ₹0.58 crore in FY25. It showed a decrease of 27.59% on a yearly basis.

BERYL DRUGS LTD. Quarterly Result Highlights

  • BERYL DRUGS LTD. reported revenue of ₹7.57 crore in Jun 2026, compared with ₹5.47 crore in Mar 2026, representing an increase of 38.39% on a quarter-on-quarter (QoQ) basis.
  • BERYL DRUGS LTD. reported an operating profit of ₹0.27 crore in Jun 2026, compared with ₹0.87 crore in Mar 2026, representing a decrease of 68.97% on a quarter-on-quarter (QoQ) basis.
  • BERYL DRUGS LTD. reported a profit of ₹0.22 crore in Jun 2026, compared with ₹0.56 crore in Mar 2026, reflecting a decrease of 60.71% on a QoQ basis.
  • The earnings per share (EPS) of BERYL DRUGS LTD. stood at ₹1.14 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
27.82%
FII
0.00%
Other DII
0.00%
Retail and other
72.18%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
12.06
P/E
19.50
P/B
1.23
ROE
4.30%
D/E
0.25
ROCE
7.56%
Div. Yield
0.00%
EPS(TTM)
0.84
Turnover
1.43
EV/EBITDA
5.65
Net Margin
2.23%
Op. Margin
12.91%
ROA
4.14%
Quick Ratio
0.83
Curr. Ratio
3.27
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Beryl Drugs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Beryl Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BERYL DRUGS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹21.15₹26.73₹26.89₹14.60
Other Income₹1.41₹0.40₹0.27₹0.16
Total Revenue₹22.55₹27.12₹27.16₹14.77
Total Expenses₹21.69₹26.12₹26.17₹15.72
Profit Before Tax₹0.87₹1.01₹0.98-₹0.95
Tax₹0.29₹0.24₹0.22-₹0.29
Profit After Tax₹0.58₹0.77₹0.77-₹0.66
EPS - Basic₹1.14₹1.52₹1.51-₹1.30
EPS - Diluted₹1.14₹1.52₹1.51-₹1.30

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.59₹0.85₹1.01₹0.98
Income before WC changes₹2.29₹2.51₹2.54₹2.09
Change in Assets₹1.28₹2.06-₹0.29₹0.14
Change in Liabilities₹0.24-₹1.09-₹1.23₹0.32
Change in WC₹1.52₹0.96-₹1.52₹0.46
Cash flow from Operations₹3.65₹3.29₹0.82₹2.48
Cash flow from Investing-₹2.16-₹1.05-₹1.08-₹1.30
Cash flow from Financing-₹2.03-₹1.56₹0.10-₹1.17
Total Cash Flow-₹0.54₹0.69-₹0.16₹0.01
Cash (Start of the year)₹0.81₹0.12₹0.28₹0.27
Cash (End of the year)₹0.27₹0.81₹0.12₹0.28

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹6.92₹7.36₹7.20₹7.20
Current Assets₹9.04₹10.12₹10.32₹10.63
Total Assets₹15.96₹17.49₹17.51₹17.82
Current Liabilities₹4.30₹5.76₹6.33₹8.49
Net Current Asset₹4.74₹4.37₹3.99₹2.14
Non-Current Liabilities₹2.16₹2.81₹3.12₹2.04
Equity Capital₹9.50₹8.92₹8.07₹7.29
Total Equity & Liabilities₹15.96₹17.49₹17.51₹17.82
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
23.98
3294
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 3294
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.05
Neutral
ATR (14)
2.26
Neutral
STOCH(9,6)
67.65
Neutral
STOCH RSI (14)
33.67
Neutral
ADX(9)
31.01
Bearish
UO(9)
65.11
Neutral
ROC(12)
-2.48
Bearish
WillR(14)
-45.9
Neutral
Period
Simple value
Exponential vaue
5D
23.71
23.85
10D
23.9
23.86
20D
23.81
23.73
50D
22.92
23.21
100D
22.38
22.74
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
BERYL DRUGS LTD. Share Price
BERYL DRUGS LTD.
Pharmaceuticals
Add Stock
Add Another

BERYL DRUGS LTD. Share Price FAQs

BERYL DRUGS LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837